The MedicX Fund Limited Scrip Dividend Declaration and total voting rights (2283R)

TIDMMXF

RNS Number : 2283R

The MedicX Fund Limited

13 June 2018

For immediate release

13 June 2018

MedicX Fund Limited

("MedicX ", "the Fund" or "the Company")

Scrip Dividend Declaration and total voting rights

MedicX Fund (LSE: MXF) announces that, pursuant to its scrip dividend scheme (the "Scrip Dividend Alternative"), elections were received in respect of 4.7 per cent. of the ordinary shares in issue as at the record date of 18 May 2018. Electing shareholders will receive ordinary shares of no par value in the Company ("Shares") in lieu of receiving cash for the June 2018 dividend in respect of the quarter ended 31 March 2018. Accordingly, 368,440 Shares will be sold out of treasury by the Company on 29 June 2018 to shareholders who elected to participate in the Scrip Dividend Alternative.

The Shares will rank pari passu with the existing ordinary shares.

Total voting rights:

As announced on 8 June, MedicX issued 3,750,000 ordinary shares from treasury as part consideration for the acquisition of the One Medical portfolio. In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of ordinary shares of the Company in issue as at 12 June 2018 was 432,730,576 (excluding treasury shares) with each share holding one voting right. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.

Following the dividend payment date and the sale out of treasury of 368,440 Shares under the Scrip Dividend Alternative, the Company is expected to have 436,002,399 ordinary shares in issue, of which 2,903,383 will be held in treasury. Accordingly, the total number of voting rights in issue as at 29 June 2018 is expected to be 433,099,016 in the absence of any further transactions in the Company's ordinary shares before 29 June 2018.

In addition, the Company has 14,771,668 ordinary shares of no par value remaining under its block listing facility.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).

End

For further information please contact:

   Octopus Healthcare Adviser Limited                                  [phone] 
   Octopus Healthcare Group                                               [phone] 

Mike Adams, Executive Chairman

   Buchanan                                                                     [phone] 

Charles Ryland/Henry Wilson

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is a specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 166 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over GBP1.4 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages GBP7.7 billion of funds for more than 50,000 retail and institutional investors as well as supplying energy to more than 180,000 customers.

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or form part of, this announcement.

The Company's Legal Entity Identifier is 2138008POF35FTNFCB25

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

MSCEAKKDFFDPEEF

(END) Dow Jones Newswires

June 13, 2018 02:17 ET (06:17 GMT)